Your browser doesn't support javascript.
loading
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
Tang, Suping; Ni, Jun; Chen, Bohua; Sun, Fei; Huang, Jinbo; Ni, Songshi; Tang, Zhiyuan.
Afiliação
  • Tang S; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.
  • Ni J; Department of Respiratory and Critical Care Medicine, The Affiliated Wuxi Second People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
  • Chen B; Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, Fujian, China.
  • Sun F; Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.
  • Huang J; Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.
  • Ni S; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.
  • Tang Z; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.
BMC Cancer ; 22(1): 525, 2022 May 09.
Article em En | MEDLINE | ID: mdl-35534807
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China